Lisa Grönnert

Lisa Grönnert

Auto-generated profile, based on publicly available information

Lisa Grönnert

Institute for Regenerative Medicine, University of Zurich, 8952, Schlieren, Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RRRuslan Rust
Ruslan Rust
LGLisa Grönnert
Lisa Grönnert
CGChristina Gantner
Christina Gantner
AEAlinda Enzler
Alinda Enzler
GMGeertje Mulders
Geertje Mulders
MSMartin Schwab
Martin Schwab
Significance: Patients suffering from ischemic strokes have limited therapeutic options and are often left with considerable disabilities. To promote neurological recovery, angiogenesis has been proposed as a promising therapeutic target. So far, experimental efforts to enhance vessel growth have almost exclusively focused on vascular growth factor supplementation; this approach has been shown not to be clinically viable due to hemorrhagic risks. Here, we pursued an alternative approach by targeting the guidance molecule Nogo-A, which has been recently shown to inhibit developmental central nervous system angiogenesis. Blockage of the Nogo-A pathway results in restoration of a mature vascular bed within the periinfarct zone. Moreover, we observe enhanced recovery-associated tissue responses and regain of motor functions that strongly correlate with vascular growth.

1 March 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RRRuslan Rust
Ruslan Rust
LGLisa Grönnert
Lisa Grönnert
BDBerre Dogançay
Berre Dogançay
MSMartin E. Schwab
Martin E. Schwab
The mouse retina provides an excellent model for studying angiogenesis. Recent advancements in high-throughput microscopy and image analysis provide great tools to visualize and describe the complexity of the retinal vascular architecture in a detailed and comprehensive way. Most developmental studies have focused on only a few parameters mostly in the inner-most layers that do not describe the entirety of the three-dimensional vascular network. Here, we analyzed the entire three-dimensional retinal vascular architecture and its growth and remodeling starting from the age of postnatal day 3 to 4 months in mice. We show plexus specific characteristics of the vasculature in terms of vascular tissue fraction, branching and length of the blood vessels, and distance and distribution between single capillaries. Such detailed knowledge is of particular interest, as it has become apparent that disease-specific mechanisms and treatments affect the retinal vasculature often in a plexus specific way.

20 March 2020 in Frontiers in Neuroscience
Verified
Journal Article
Open access
PDF file
RRRuslan Rust
Ruslan Rust
TKTunahan Kirabali
Tunahan Kirabali
LGLisa Grönnert
Lisa Grönnert
BDBerre Dogancay
Berre Dogancay
YLYanuar D. P. Limasale
Yanuar D. P. Limasale
MSMartin E. Schwab
Martin E. Schwab
The distinct organization of the brain’s vasculature ensures the adequate delivery of oxygen and nutrients during development and adulthood. Acute and chronic pathological changes of the vascular system have been implicated in many neurological disorders including stroke and dementia. Here, we describe a fast, automated method that allows the highly reproducible, quantitative assessment of distinct vascular parameters and their changes based on the open source software Fiji (ImageJ). In particular, we developed a practical guide to reliably measure aspects of growth, repair and maturation of the brain’s vasculature during development and neurovascular disease in mice and humans. The script can be used to assess the effects of different external factors including pharmacological treatments or disease states. Moreover, the procedure is expandable to blood vessels of other organs and vascular in vitro models.

27 December 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RRRuslan Rust
Ruslan Rust
RWRebecca Z. Weber
Rebecca Z. Weber
LGLisa Grönnert
Lisa Grönnert
GMGeertje Mulders
Geertje Mulders
MMMichael A. Maurer
Michael A. Maurer
MSMartin E. Schwab
Martin E. Schwab
Angiogenesis is a key restorative process following stroke but has also been linked to increased vascular permeability and blood brain barrier (BBB) disruption. Previous pre-clinical approaches primarily focused on the administration of vascular endothelial growth factor (VEGF) to promote vascular repair after stroke. Although shown to improve angiogenesis and functional recovery from stroke, VEGF increased the risk of blood brain barrier disruption and bleedings to such an extent that its clinical use is contraindicated. As an alternative strategy, antibodies against the neurite growth inhibitory factor Nogo-A have recently been shown to enhance vascular regeneration in the ischemic central nervous system (CNS); however, their effect on vascular permeability is unknown. Here, we demonstrate that antibody-mediated Nogo-A neutralization following stroke has strong pro-angiogenic effects but does not increase vascular permeability as opposed to VEGF. Moreover, VEGF-induced vascular permeability was partially prevented when VEGF was co-administered with anti-Nogo-A antibodies. This study may provide a novel therapeutic strategy for vascular repair and maturation in the ischemic brain.

1 September 2019 in Trends in Neurosciences
Verified
Journal Article
Closed access
RRRuslan Rust
Ruslan Rust
LGLisa Grönnert
Lisa Grönnert
RWRebecca Zoe Weber
Rebecca Zoe Weber
GMGeertje Mulders
Geertje Mulders
MSMartin E. Schwab
Martin E. Schwab

1 December 2018 in Trends in Neurosciences
Verified
Journal Article
Closed access
RRRuslan Rust
Ruslan Rust
LGLisa Grönnert
Lisa Grönnert
MSMartin E. Schwab
Martin E. Schwab